Advertisement

Topics

uBiome, Inc. Company Profile

03:18 EST 12th December 2018 | BioPortfolio

Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness. uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney. Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit www.uBiome.com.


News Articles [50 Associated News Articles listed on BioPortfolio]

Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database

uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 millio...

Microbiome Startup uBiome Expands into Drug Research with $83M

Biotech company uBiome started as a “citizen science” project that collected and studied microbiome samples in order to learn how the trillions of bacteria living in and on people’s bodies affec...

Series C lands $83mm for uBiome

Microbial genomics firm uBiome Inc. raised $83mm in its Series C financing led by OS Fund, which was joined by investors including 8VC, Y Combinator, and Dentsu Ventures. The six-year-old firm will us...

Bay Area’s uBiome Secures $83 Million as It Moves into Drug Development, Taps ex-Novartis CEO for...

San Francisco-based uBiome snagged $83 million in a Series C financing round and also tapped industry veteran Joe Jimenez, the former chief executive officer of Swiss pharma giant Novartis, to its boa...

uBiome raises $83m financing to advance product portfolio

OS Fund led the round, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. The microbiome plays a vital role in every aspect The post uBiome raises ...

uBiome Appoints Dr. Sünje Pamp, PhD, Microbial Ecology and Infectious Diseases Researcher, To its Scientific Advisory Board

SAN FRANCISCO (PRWEB) October 29, 2018 uBiome, the leader in microbial genomics, announces the addition of Dr. Sünje Pamp, PhD,...

uBiome Awards Grant to University of Alicante Researchers to Study Influence of Diet on Gut Microbiome and Sports Performance

SAN FRANCISCO (PRWEB) November 09, 2018 Through its Microbiome Grant Initiative , uBiome, the leader in microbial genomics, has awa...

uBiome Awards Grant to The Ohio State University to Study Microbiome Composition in Perinatal Women and Their Infants

SAN FRANCISCO (PRWEB) November 20, 2018 Through its Microbiome Grant Initiative , uBiome, the leader in microbial genomics, has awa...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Silver Diamine Fluoride and Gingivitis in Geriatric Patients

Gingivitis in the geriatric population is one of the growing global public health concerns, thus finding the most effective and non-invasive approach to prevent and treat gingivitis in the...

Companies [1 Associated Companies listed on BioPortfolio]

uBiome, Inc.

Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome’s com...

More Information about "uBiome, Inc." on BioPortfolio

We have published hundreds of uBiome, Inc. news stories on BioPortfolio along with dozens of uBiome, Inc. Clinical Trials and PubMed Articles about uBiome, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of uBiome, Inc. Companies in our database. You can also find out about relevant uBiome, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record